News

March 31, 2008 - Over the years, interventional cardiologists have made many improvements in percutaneous coronary intervention (PCI) for patients with heart attack, among the most important,...

March 20, 2008 - ARUP Laboratories and the University of Utah's Department of Pathology have released ARUP Consult version 2.3, a free laboratory test selection support tool for PDA devices that...

February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in...

February 19, 2008 - Among patients with acute myocardial infarction (AMI), prior statin therapy is associated with better perfusion after primary angioplasty of the infarct-related artery,...

February 18, 2008 - Abbott received FDA approval for SIMCOR a fixed-dose combination of two cholesterol therapies, Niaspan (Abbott’s proprietary niacin extended-release) and simvastatin, offering...

January 30, 2008 - Iroko Pharmaceuticals (Iroko) acquired all non-U.S. commercial rights to Aggrastat (tirofiban HCl) from Merck & Co. Inc., used for patients undergoing coronary angioplasty...

December 18, 2007 - Forest Laboratories Inc. and Mylan Inc. announced today that the FDA cleared the novel beta blocker Bystolic (nebivolol) for the treatment of hypertension.

Bystolic is...

December 11, 2007 - The FDA issued its final assessment of two long-term studies in patients with severe gastroesophageal reflux disease (GERD) who were being treated with either Prilosec or...

November 5, 2007 - New data released today at the American Heart Association's Scientific Sessions showed that Abbott's SIMCOR, an investigational, fixed-dose combination of Abbott's proprietary...

November 4, 2007 – Single photon emission computed tomography (SPECT) can identify which patients will benefit more from undergoing percutaneous coronary intervention (PCI) than receiving medical...

September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application (sNDA) for a modified dosing regimen of Angiomax (bivalirudin) for the...

September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy...

August 7, 2007 - The American College of Cardiology and the American Heart Association have jointly released revised Guidelines for the Management of Patients with Unstable Angina (UA)/Non-ST-...

July 31, 2007 - GlaxoSmithKline announced the recommendation of an FDA advisory committee to support Avandia’s (rosiglitazone maleate), an oral anti-diabetic medicine, continued availability to...

June 26, 2007 - Physicians who report quality measures for care delivered to Medicare beneficiaries July 1–December 31, 2007 may receive an additional 1.5 percent incentive payment, subject to a...

June 21, 2007 - Exforge, a single-tablet combination of two of the most prescribed high blood pressure medicines, has been granted final FDA approval for use in patients who suffer from high blood...

June 4, 2007 — Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...

June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study...

May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m....

April 16, 2007 — LegalView.com has added a database of up-to-date information about FDA-approved drugs, which includes practice areas on unsafe drugs, recall information for medications such as...

Jan. 5, 2007 — An announcement from AstraZeneca is expected soon about the company’s experimental heart drug AGI-1067, the company’s partner AtheroGenics Inc. hopes to present results from a...

Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward...

An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to...

San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007...

A large California-based study has shown that patients with heart failure who start taking statins, compared with those who don't, will live longer and have a lower hospitalization risk regardless...

FDA and Duke Clinical Research Institute will be working to develop a new generation of tools that enable early identification of potential cardiac side effects of drugs and devices. The agency...

Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve may reduce the occurrence of atrial fibrillation, a common heart rhythm...

Drugs traditionally used for the treatment of gastric ulcers could have therapeutic potential in chronic heart failure, according to new research coming out of Japan.

One outcome showed...

Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor

Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address...